alectinib hydrochloride (Biosynth Carbosynth)
Structured Review

Alectinib Hydrochloride, supplied by Biosynth Carbosynth, used in various techniques. Bioz Stars score: 90/100, based on 2 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/alectinib hydrochloride/product/Biosynth Carbosynth
Average 90 stars, based on 2 article reviews
Images
1) Product Images from "Alectinib-Loaded Chitosan–Alginate Nanoparticles: A Novel Synthesis Method with In Vitro and In Vivo Evaluations"
Article Title: Alectinib-Loaded Chitosan–Alginate Nanoparticles: A Novel Synthesis Method with In Vitro and In Vivo Evaluations
Journal: Pharmaceutics
doi: 10.3390/pharmaceutics17040492
Figure Legend Snippet: The inhibitory role of Alectinib on EML4-ALK-positive NSCLC.
Techniques Used:
Figure Legend Snippet: The synthesis process of Alectinib-loaded chitosan–alginate nanoparticles.
Techniques Used:
Figure Legend Snippet: The chromatogram of Alectinib 12.5 µg/mL solution in methanol and the chromatogram of the mobile phase.
Techniques Used:
Figure Legend Snippet: The encapsulation efficiency (EE %), ratios, solubilizing agents, and the method used of NP optimization.
Techniques Used: Encapsulation, Emulsification
Figure Legend Snippet: The FTIR spectra of Alectinib, chitosan, alginate, and their mixture.
Techniques Used:
Figure Legend Snippet: Comparison of characteristic FTIR absorption bands of Alectinib, chitosan, alginate, and their physical mixture.
Techniques Used: Comparison
Figure Legend Snippet: DSC thermograms of pure Alectinib, chitosan, alginate, and ACANPs showing changes in thermal behavior, indicating drug encapsulation and transformation into the amorphous state.
Techniques Used: Encapsulation, Transformation Assay
Figure Legend Snippet: An in vitro release plot of Alectinib at 6.8 pH from the ACANPs and the free drug.
Techniques Used: In Vitro
Figure Legend Snippet: ( A ) LC-MS/MS chromatogram for the blank sample with no peak of Alectinib. ( B ) Alectinib at 483,300 Da, height: 2.48 × 10 3 cps, RT: 0.504 min. ( C ) Rosuvastatin (internal standard) at 482,200 Da, height: 1.64 × 10 5 cps, RT: 0.750 min.
Techniques Used: Liquid Chromatography with Mass Spectroscopy
Figure Legend Snippet: The plasma concentration–time profiles of Alectinib in the ACANP formulation and the free drug.
Techniques Used: Clinical Proteomics, Concentration Assay, Formulation
Figure Legend Snippet: Pharmacokinetic parameters of free Alectinib and ACANP formulation.
Techniques Used: Formulation
